Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sestant is an Italian financial holding company associated with the Marcucci family and is best known as an investment and control vehicle linked to Kedrion, a plasma-derived therapeutics business. Publicly available sources describe Sestant as overseeing the international assets of the Marcucci family rather than operating as a standalone biotech, pharma, or healthcare product company. Its relevance to life sciences appears to come primarily through ownership, governance, and transaction activity involving Kedrion and related plasma-sector assets. Available evidence does not indicate that Sestant itself develops therapeutic products, runs a clinical pipeline, or operates as a drug discovery platform company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sestant.